| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |